Merck and UAB Recruiting 16 to 26 Year Old Mothers Who Just Gave Birth to Enroll in Gardasil 9 Vaccine Trials

Merck and UAB Recruiting 16 to 26 Year Old Mothers Who Just Gave Birth to Enroll in Gardasil 9 Vaccine Trials

by Brian Shilhavy
Editor, Health Impact News
The University of Alabama at Birmingham (UAB) in collaboration with Merck pharmaceutical company is planning to conduct Gardasil 9 vaccine trials on postpartum mothers between the ages of 16 to 26 immediately after giving birth at the UAB hospital.
According to ClinicalTrials.gov, the desired outcome of this study is to have more young women vaccinated with the Gardasil vaccine, because they do not believe enough young women are being vaccinated:

Due to low HPV vaccine uptake in the US, innovative approaches to vaccinating vulnerable populations are necessary in order to maximize the cancer prevention potential of this vaccine.

Previous studies on the Gardasil vaccine have shown that young women who are in the hospital due to giving birth are open to receiving the Gardasil vaccine, particularly Hispanic populations:

The puerperium is a time period when women are engaged in the healthcare system and have almost universal access to affordable health care.
Two prior studies have shown that postpartum HPV vaccination is acceptable to patients, and high rates of vaccination were achieved in these primarily Hispanic populations.

Merck and UAB want to test the vaccine on 16 to 26 year old postpartum mothers because “the immune response in young women is less robust than in adolescents,” and because “no studies have examined immunogenicity in postpartum women specifically.”
Therefore, 16 to 26 year old young mothers who have just given birth at the UAB hospital will become test subjects of the Gardasil 9 vaccine.
The study is scheduled to start on June 1, 2018.
The “Responsible Party” who apparently designed the study at UAB is Professor Warner Huh.
The contact person for the clinical vaccine trials is Sarah Dilley, MD 205-934-2749 sdilley@uabmc.edu. (Source.)

Should Young Mothers Who Have Just Given Birth Participate in these Vaccine Trials?

Protests over the Gardasil HPV vaccine in the streets of Colombia. Story.
The Gardasil HPV vaccine is probably the most controversial vaccine in the world right now, with many countries withdrawing their approval of the dangerous vaccine.
Outside of the U.S. parents and organizations have taken legal action against Merck for injuries and deaths due to Gardasil, and in France one doctor who previously worked for Merck predicted that Gardasil would become “the greatest medical scandal of all time.”
Negative press regarding the HPV vaccine can be found outside the U.S. in countries like Spain, Japan, Ireland, Denmark, the UK, India, and many others.
As we just reported recently, the documentary film trilogy, Sacrificial Virgins, which recounts the stories of many young women injured by the HPV vaccine, received the prestigious Best of the Festival award, and the Watchdog Spirit Award  in recognition of the investigation “in search of truth and justice” at the Watchdog Film Festival, held in Brisbane, Australia. (Story here.)
Thanks to U.S. laws that protect pharmaceutical companies from being sued due to damages and deaths resulting from vaccines, much of the controversy surrounding Gardasil has been censored in the corporate “mainstream” media.
In the alternative media, however, millions of Americans are reading about the controversial vaccine, and it has been the #1 topic on Health Impact News for the past 3 years.
Will these young mothers in Alabama have sufficient information to make the decision to participate in these Gardasil vaccine trials just after giving birth? Will they understand the potential risks for harm, which includes heart disease (POTS), premature menopause (“Primary Ovarian Failure”) and a whole list of autoimmune disorders that have been hidden from the public but revealed by a 2017 study done in Mexico?
Reference
Postpartum HPV Vaccination – ClinicalTrials.gov

Thanks to: http://vaccineimpact.com